Comparative Study, Safety and Efficacy, Ahmed Glaucoma Drainage Device, Model M4 Model S2 in Neovascular Glaucoma
Primary Purpose
Neovascular Glaucoma
Status
Unknown status
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Surgical Implant of Ahmed Glaucoma Drainage Device, model M4 and S2
Sponsored by
About this trial
This is an interventional treatment trial for Neovascular Glaucoma focused on measuring Ahmed implant, Neovascular Glaucoma, Intraocular pressure
Eligibility Criteria
Inclusion Criteria:
- Patients with diagnosis of Neovascular glaucoma
- High IOP despite topical treatment
Exclusion Criteria:
- Pregnant women
- Mental disorders
- Previous glaucoma surgery
- Patients older than 18 years
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Active Comparator
Arm Label
S2
M4
Arm Description
Surgically Implant an Ahmed Glaucoma Drainage Device Model S2 in Neovascular Glaucoma Patients and evaluate the IOP evolution, complications and need for medication to control IOP
Surgically Implant an Ahmed Glaucoma Drainage Device Model M4 in Neovascular Glaucoma Patients and evaluate the IOP evolution, complications and need for medication to control IOP
Outcomes
Primary Outcome Measures
Number of participants with adverse effects
Secondary Outcome Measures
Intraocular pressure
Full Information
NCT ID
NCT02260219
First Posted
July 17, 2014
Last Updated
October 6, 2014
Sponsor
Asociación para Evitar la Ceguera en México
1. Study Identification
Unique Protocol Identification Number
NCT02260219
Brief Title
Comparative Study, Safety and Efficacy, Ahmed Glaucoma Drainage Device, Model M4 Model S2 in Neovascular Glaucoma
Official Title
Comparative Study of the Safety and Efficacy of the Ahmed Glaucoma Valve Drainage Device, Model M4 (High Density Porous Polyethylene) and the Model S2 (Polypropylene) in Patients With Neovascular Glaucoma
Study Type
Interventional
2. Study Status
Record Verification Date
September 2014
Overall Recruitment Status
Unknown status
Study Start Date
January 2012 (undefined)
Primary Completion Date
February 2013 (Actual)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Asociación para Evitar la Ceguera en México
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Objective: Prospectively evaluate the safety and efficacy of the Ahmed Glaucoma Drainage Device, model M4 compared with the model S2.
Method: Mexican patients with Neovascular Glaucoma will be randomly included for each group (M4 and S2). They will be operated using conventional techniques and creating a sub-episcleral tunnel to place the valve's tube in the anterior chamber. They will be monitoring for one year and the results will be evaluated with respect to a postoperative reduction in pressure, changes in visual acuity, the need for drugs and complications, in addition to the demographic characteristics of each group.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neovascular Glaucoma
Keywords
Ahmed implant, Neovascular Glaucoma, Intraocular pressure
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
42 (Actual)
8. Arms, Groups, and Interventions
Arm Title
S2
Arm Type
Active Comparator
Arm Description
Surgically Implant an Ahmed Glaucoma Drainage Device Model S2 in Neovascular Glaucoma Patients and evaluate the IOP evolution, complications and need for medication to control IOP
Arm Title
M4
Arm Type
Active Comparator
Arm Description
Surgically Implant an Ahmed Glaucoma Drainage Device Model M4 in Neovascular Glaucoma Patients and evaluate the IOP evolution, complications and need for medication to control IOP
Intervention Type
Procedure
Intervention Name(s)
Surgical Implant of Ahmed Glaucoma Drainage Device, model M4 and S2
Intervention Description
Surgically Implant an Ahmed Glaucoma Drainage Device Models S2 and M4, evaluare IOP evolution, complications and need for medication to control IOP
Primary Outcome Measure Information:
Title
Number of participants with adverse effects
Time Frame
1 year
Secondary Outcome Measure Information:
Title
Intraocular pressure
Time Frame
1 year
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients with diagnosis of Neovascular glaucoma
High IOP despite topical treatment
Exclusion Criteria:
Pregnant women
Mental disorders
Previous glaucoma surgery
Patients older than 18 years
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Felix Gil-Carrasco, MD
Organizational Affiliation
52 55 10841400
Official's Role
Study Director
12. IPD Sharing Statement
Learn more about this trial
Comparative Study, Safety and Efficacy, Ahmed Glaucoma Drainage Device, Model M4 Model S2 in Neovascular Glaucoma
We'll reach out to this number within 24 hrs